Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition
10:42am, Tuesday, 27'th Aug 2024
McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.
Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 bln
08:16am, Monday, 26'th Aug 2024
Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's business and administrative services unit, Core V
McKesson to acquire controlling stake in Core Ventures for $2.49 billion in cash
08:08am, Monday, 26'th Aug 2024
McKesson Corp. MCK, -1.56% said Monday it has agreed to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures, LLC , or Core Ventures, a physician-owned community oncolo
14 Upcoming Dividend Increases Including 2 Kings
12:29pm, Thursday, 22'nd Aug 2024
Fourteen upcoming dividend increases, including two Dividend Kings: Nordson Corp with a 14.7% increase and Dover Corp with a 1% increase. New challengers Cactus Inc. and Murphy USA join the list with
McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?
11:55am, Monday, 19'th Aug 2024
McKesson's (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
10:02am, Thursday, 15'th Aug 2024
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
3 Healthcare Stocks to Sell in August Before They Crash & Burn
12:02pm, Friday, 09'th Aug 2024
The stock market is currently in a rotation. Traders are moving capital from aggressive growth and technology names to find safety in other sectors of the market.
McKesson Revenue Hurt by Supply and Demand Issues for Weight-Loss Drugs
03:01pm, Thursday, 08'th Aug 2024
McKesson (MCK) shares tumbled Thursday, a day after the healthcare services provider warned that limited supply of GLP-1 weight-loss drugs is hurting sales.
McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y
10:15am, Thursday, 08'th Aug 2024
McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.2% on Thursday.
McKesson (MCK) Reports Q1 Earnings: What Key Metrics Have to Say
07:00pm, Wednesday, 07'th Aug 2024
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street e
McKesson (MCK) Tops Q1 Earnings Estimates
06:25pm, Wednesday, 07'th Aug 2024
McKesson (MCK) came out with quarterly earnings of $7.88 per share, beating the Zacks Consensus Estimate of $7.16 per share. This compares to earnings of $7.27 per share a year ago.
McKesson misses quarterly revenue as U.S. pharmaceutical segment weighs
05:02pm, Wednesday, 07'th Aug 2024
McKesson Corp reported weaker-than-expected first-quarter revenue on Wednesday due to soft demand for branded and specialty drugs that dragged sales down in its U.S. pharmaceuticals segment.
3 Healthcare Stocks Positioned for Possible Market Outperformance
11:40am, Wednesday, 07'th Aug 2024
So far in 2024, healthcare stocks have run into periodic earnings challenges compared to historical first quarters. For example, quarterly earnings for healthcare stocks across the board were down 25%
Here's Why McKesson (MCK) is a Strong Momentum Stock
10:51am, Wednesday, 07'th Aug 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
